Identification of the Novel HLA‐B*13:206 Allele by Sanger Dideoxy Sequencing
HLA · 2026-04 · 107 (4)
DOI: 10.1111/tan.70712 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 12.04.2026. Verfasst von Caifeng Long und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China. Hauptthemen laut MEDLINE: Exons, Alleles, Sequence Analysis, DNA, HLA-B13 Antigen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐B*13:206 differs from HLA‐B*13:01:01:01 by one nucleotide substitution in codon 194 in exon 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Laboratory, Beijing Red Cross Blood Center, Beijing, China.
ORCID-Profile: Chengyan Fan, Tiecheng Sun, Yanjun Jia
Zitieren
APA
Long, C., Li, D., Fan, C., Sun, T., & Jia, Y. (2026). Identification of the Novel HLA‐B*13:206 Allele by Sanger Dideoxy Sequencing. HLA, 107(4). https://doi.org/10.1111/tan.70712
Vancouver
Long C, Li D, Fan C, Sun T, Jia Y. Identification of the Novel HLA‐B*13:206 Allele by Sanger Dideoxy Sequencing. HLA. 2026;107(4). doi:10.1111/tan.70712
BibTeX
@article{Long2026,
author = {Long, Caifeng and Li, Dongmei and Fan, Chengyan and Sun, Tiecheng and Jia, Yanjun},
title = {Identification of the Novel HLA‐B*13:206 Allele by Sanger Dideoxy Sequencing},
journal = {HLA},
year = {2026},
volume = {107},
number = {4},
doi = {10.1111/tan.70712}
}
EUVIMED